NICKEL TARTRATE

[Ni++].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O

InChIKey=XRLUJVFOGKUSMQ-ZVGUSBNCSA-L

InChI=1S/C4H6O6.Ni/c5-1(3(7)8)2(6)4(9)10;/h1-2,5-6H,(H,7,8)(H,9,10);/q;+2/p-2/t1-,2-;/m1./s1

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Nickel tatrate a salt of tatric acid. It is used as a catalyst for enantioselective hydrogenation.

Conditions

Condition	Modality	Targets	Highest Phase	Product
Unknown 2596

PubMed

Title	Date	PubMed
Synthesis, characterization and antimicrobial activity of some mixed ligand Co(II) and Ni(II) complexes.	2003-07-10	12848367
From local adsorption stresses to chiral surfaces: (R,R)-tartaric acid on Ni(110).	2002-01-23	11792223

Patents

In Vivo Use Guide

Unknown

Route of Administration: Unknown

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:56:03 GMT 2025` Edited by `admin` on `Mon Mar 31 18:56:03 GMT 2025`
Record UNII	8XOZ193139
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

NICKEL TARTRATE

Systematic Name

English

BUTANEDIOIC ACID,2,3-DIHYDROXY- ( 2R,3R)-, NICKEL SALT (1:1)

Preferred Name

English

Nickel tartrate [WHO-DD]

Common Name

English

Code System Code Type Description

FDA UNII

8XOZ193139